Streetbeat News

Earnings

AKAM

Akamai Technologies shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:06 pm

WOW

WideOpenWest (NYSE:WOW) reported Q2 2024 GAAP EPS of $(0.13), beating the estimate of $(0.14). However, sales of $158.8M missed the $159.145M estimate and were down 8% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:06 pm

LQDT

Over the past three months, four analysts have evaluated Liquidity Services (NASDAQ:LQDT), with all ratings being 'Somewhat Bullish'. The average 12-month price target remains steady at $27.00. Liquidity Services has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, and maintains a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 8:05 pm

AKAM

Akamai Technologies (NASDAQ: AKAM) reported Q2 2024 adjusted EPS of $1.58, beating the estimate of $1.53. Sales were $979.580M, surpassing the $977.242M estimate. EPS decreased by 3.66% YoY, while sales increased by 4.69% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:05 pm

QRHC

Quest Resource Holding (NASDAQ:QRHC) reported Q2 2024 adjusted EPS of $0.03, beating the $(0.01) estimate by 400%. However, sales of $73.145M missed the $76.700M estimate by 4.63%, marking a 1.81% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:04 pm

DNMR

Danimer Scientific (NYSE:DNMR) reported Q2 2024 GAAP EPS of $(0.19), beating the $(0.24) estimate, but sales of $7.628M missed the $9.270M estimate. EPS improved by 50% YoY, while sales decreased by 40.71% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:04 pm

CUTR

Cutera (NASDAQ:CUTR) reported Q2 sales of $34.4 million, missing the analyst consensus estimate of $38.695 million by 11.10%. This represents a 43.81% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:04 pm

PODD

Insulet (NASDAQ:PODD) reported Q2 2024 earnings per share of $0.55, missing the analyst estimate of $0.56 by 1.79%. However, the company reported sales of $488.50 million, beating the estimate of $463.31 million by 5.44% and showing a 23.20% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:03 pm

EXPE

Expedia Group (NASDAQ:EXPE) reported Q2 2024 adjusted EPS of $3.51, beating the $3.06 estimate by 14.71%. Sales were $3.558 billion, surpassing the $3.534 billion estimate by 0.67%. This represents a 21.45% increase in EPS and a 5.96% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:03 pm

GILD

Gilead Sciences (NASDAQ:GILD) reported strong Q2 2024 earnings, with an adjusted EPS of $2.01 beating the $1.60 estimate and sales of $6.954 billion surpassing the $6.719 billion estimate. This represents a significant year-over-year increase in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:03 pm